of chart diagnoses evaluated in the current study were based upon point versus lifetime prevalence. As such, positive associations between lifetime CUD comorbidity and anxiety disorders, as has been demonstrated in prior research [24,25,27], may have been more difficult to detect in the current sample. The reliance upon point prevalence diagnoses may have also influenced null findings reported above (i.e., for suicide attempt history). Future research will be necessary in order to better clarify the associations between cannabis use and anxiety in patients with BD.
